_version_ 1783504165866045440
author Moral, John Alec
Leung, Joanne
Rojas, Luis A.
Ruan, Jennifer
Zhao, Julia
Sethna, Zachary
Ramnarain, Anita
Gasmi, Billel
Gururajan, Murali
Redmond, David
Askan, Gokce
Bhanot, Umesh
Elyada, Ela
Park, Youngkyu
Tuveson, David A.
Gönen, Mithat
Leach, Steven D.
Wolchok, Jedd D.
DeMatteo, Ronald P.
Merghoub, Taha
Balachandran, Vinod P.
author_facet Moral, John Alec
Leung, Joanne
Rojas, Luis A.
Ruan, Jennifer
Zhao, Julia
Sethna, Zachary
Ramnarain, Anita
Gasmi, Billel
Gururajan, Murali
Redmond, David
Askan, Gokce
Bhanot, Umesh
Elyada, Ela
Park, Youngkyu
Tuveson, David A.
Gönen, Mithat
Leach, Steven D.
Wolchok, Jedd D.
DeMatteo, Ronald P.
Merghoub, Taha
Balachandran, Vinod P.
author_sort Moral, John Alec
collection PubMed
description
format Online
Article
Text
id pubmed-7060130
institution National Center for Biotechnology Information
language English
publishDate 2020
record_format MEDLINE/PubMed
spelling pubmed-70601302020-08-19 ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity Moral, John Alec Leung, Joanne Rojas, Luis A. Ruan, Jennifer Zhao, Julia Sethna, Zachary Ramnarain, Anita Gasmi, Billel Gururajan, Murali Redmond, David Askan, Gokce Bhanot, Umesh Elyada, Ela Park, Youngkyu Tuveson, David A. Gönen, Mithat Leach, Steven D. Wolchok, Jedd D. DeMatteo, Ronald P. Merghoub, Taha Balachandran, Vinod P. Nature Article 2020-02-19 2020-03 /pmc/articles/PMC7060130/ /pubmed/32076273 http://dx.doi.org/10.1038/s41586-020-2015-4 Text en Reprints and permissions information is available at http://www.nature.com/reprints. Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Moral, John Alec
Leung, Joanne
Rojas, Luis A.
Ruan, Jennifer
Zhao, Julia
Sethna, Zachary
Ramnarain, Anita
Gasmi, Billel
Gururajan, Murali
Redmond, David
Askan, Gokce
Bhanot, Umesh
Elyada, Ela
Park, Youngkyu
Tuveson, David A.
Gönen, Mithat
Leach, Steven D.
Wolchok, Jedd D.
DeMatteo, Ronald P.
Merghoub, Taha
Balachandran, Vinod P.
ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity
title ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity
title_full ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity
title_fullStr ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity
title_full_unstemmed ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity
title_short ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity
title_sort ilc2s amplify pd-1 blockade by activating tissue-specific cancer immunity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060130/
https://www.ncbi.nlm.nih.gov/pubmed/32076273
http://dx.doi.org/10.1038/s41586-020-2015-4
work_keys_str_mv AT moraljohnalec ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity
AT leungjoanne ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity
AT rojasluisa ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity
AT ruanjennifer ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity
AT zhaojulia ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity
AT sethnazachary ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity
AT ramnarainanita ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity
AT gasmibillel ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity
AT gururajanmurali ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity
AT redmonddavid ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity
AT askangokce ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity
AT bhanotumesh ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity
AT elyadaela ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity
AT parkyoungkyu ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity
AT tuvesondavida ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity
AT gonenmithat ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity
AT leachstevend ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity
AT wolchokjeddd ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity
AT dematteoronaldp ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity
AT merghoubtaha ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity
AT balachandranvinodp ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity